FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging

[1]  K. Thursky,et al.  What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer , 2017, Current opinion in infectious diseases.

[2]  I. Namer,et al.  18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation , 2017, Nuclear Medicine and Molecular Imaging.

[3]  Michael S Hofman,et al.  How We Read Oncologic FDG PET/CT , 2016, Cancer Imaging.

[4]  C. Scheid,et al.  A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis. , 2016, The Journal of antimicrobial chemotherapy.

[5]  He Huang,et al.  Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years , 2015, Journal of Zhejiang University-SCIENCE B.

[6]  K. Thursky,et al.  Epidemiology of invasive fungal disease in lymphoproliferative disorders , 2015, Haematologica.

[7]  B. Ko,et al.  High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan , 2015, PloS one.

[8]  Rakesh Kumar,et al.  Staging and response of sternal histoplasmosis by 18F-FDG PET/CT. , 2015, Clinical nuclear medicine.

[9]  S. Harrison,et al.  Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies , 2015, Haematologica.

[10]  Kai Liu,et al.  Imaging findings of cryptococcal infection of the thoracic spine. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  D. Horn,et al.  Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry , 2014, Mycoses.

[12]  E. Anaissie,et al.  Improvement in the outcome of invasive fusariosis in the last decade. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  J. Greene,et al.  Scedosporium Infections at a Cancer Center Over a 10-Year Period (2001–2010) , 2014 .

[14]  L. Leibovici,et al.  The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia. , 2013, Leukemia research.

[15]  T. Sorrell,et al.  Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. , 2013, The Lancet. Infectious diseases.

[16]  R. Hicks,et al.  Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  W. Oyen,et al.  18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  M. Miyagawa,et al.  FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings , 2011, Annals of Hematology.

[19]  C. Maunoury,et al.  Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Bing Xu,et al.  Utility of FDG PET/CT in Guiding Antifungal Therapy in Acute Leukemia Patients With Chronic Disseminated Candidiasis , 2010, Clinical nuclear medicine.

[21]  Thomas J Walsh,et al.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  F. Dubois,et al.  Monitoring of systemic candidiasis by 18F-FDG PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  J. Perfect,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  H. Macapinlac,et al.  The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. , 2008, Medical mycology.

[25]  K. Marr,et al.  Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients , 2007, British journal of haematology.

[26]  R. Cerfolio,et al.  The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. , 2006, The Annals of thoracic surgery.

[27]  B. Barlogie,et al.  18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  W. Oyen,et al.  Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[30]  D. Kontoyiannis,et al.  Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  G. Rubini,et al.  (18)F-FDG PET/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis. , 2015, Hellenic journal of nuclear medicine.

[32]  R. Hicks,et al.  uorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia , 2012 .